Showing results (471-480 of 1,104) with videos related to
Sort By:
Pageof 111
Clinical Lung Cancer|May 30, 2018
Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in AsiaHerbert H Loong, Victoria M Raymond, Yukimasa Shiotsu, et al.Journal of Medical Economics|July 22, 2024
Population health outcomes of blood-based screening for colorectal cancer in comparison to current screening modalities: insights from a discrete-event simulation model incorporating longitudinal adherenceShaun P Forbes, Elifnur Yay Donderici, Nicole Zhang, et al.Journal of Exposure Science & Environmental Epidemiology|November 14, 2013
Geospatial relationships of air pollution and acute asthma events across the Detroit-Windsor international border: study design and preliminary resultsLawrence D Lemke, Lois E Lamerato, Xiaohong Xu, et al.Open Forum Infectious Diseases|August 14, 2024
Diverse Clinical Manifestations and Challenges of Mucormycosis: Insights From Serial CasesMarisa C Nielsen, Filipe M Cerqueira, Sri Bharathi Kavuri, et al.Clinical Lung Cancer|July 16, 2020
Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA AnalysisKaren L Reckamp, Tejas Patil, Kedar Kirtane, et al.Journal of Genetic Counseling|August 26, 2017
Physician Experiences and Understanding of Genomic Sequencing in OncologyCaroline M Weipert, Kerry A Ryan, Jessica N Everett, et al.Plos One|July 16, 2015
Adolescents' Neural Processing of Risky Decisions: Effects of Sex and Behavioral DisinhibitionThomas J Crowley, Manish S Dalwani, Susan K Mikulich-Gilbertson, et al.Gut|August 1, 1996
Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patientsP Ruszniewski, M Ducreux, J A Chayvialle, et al.The American Journal of Gastroenterology|November 30, 2000
The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumorsM Ducreux, P Ruszniewski, J A Chayvialle, et al.Cancer Chemotherapy and Pharmacology|November 17, 2001
Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenograftsR A Newman, J Yang, M Raymond, et al.Pageof 111